Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction
暂无分享,去创建一个
[1] Daniel K. Benvenuti,et al. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study. , 2023, The Lancet. Respiratory medicine.
[2] G. Foti,et al. Ultrasound Versus Computed Tomography for Diaphragmatic Thickness and Skeletal Muscle Index during Mechanical Ventilation , 2022, Diagnostics.
[3] J. Laffey,et al. Monitoring Lung Injury Severity and Ventilation Intensity during Mechanical Ventilation. , 2022, Seminars in respiratory and critical care medicine.
[4] M. Girardis,et al. Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety , 2022, Journal of Anesthesia, Analgesia and Critical Care.
[5] R. J. Omeljaniuk,et al. Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury , 2021, Drug Target Insights.
[6] M. Braga,et al. Low skeletal muscle index and myosteatosis as predictors of mortality in critically ill surgical patients. , 2021, Nutrition.
[7] J. Laffey,et al. Emerging pharmacological therapies for ARDS: COVID-19 and beyond , 2020, Intensive Care Medicine.
[8] A. Parkhomenko,et al. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use , 2020, Journal of cardiovascular pharmacology.
[9] G. Gamba,et al. Ethical Considerations in Animal Research: The Principle of 3R's. , 2020, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.
[10] L. Brochard,et al. Effects of levosimendan on respiratory muscle function in patients weaning from mechanical ventilation , 2019, Intensive Care Medicine.
[11] A. Torsello,et al. Angiotensin-(1–7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction , 2019, Intensive Care Medicine Experimental.
[12] A. Demoule,et al. Diaphragm dysfunction during weaning from mechanical ventilation: an underestimated phenomenon with clinical implications , 2018, Critical Care.
[13] A. Cohen-Solal,et al. The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion Nieminen, , 2022 .
[14] G. Scheffer,et al. Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice , 2015, Critical Care.
[15] A. Girbes,et al. Diaphragm fiber strength is reduced in critically ill patients and restored by a troponin activator. , 2014, American journal of respiratory and critical care medicine.
[16] S. Powers,et al. Ventilator-induced diaphragm dysfunction: cause and effect. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.
[17] D. Stegeman,et al. The calcium sensitizer levosimendan improves human diaphragm function. , 2012, American journal of respiratory and critical care medicine.
[18] L. Papazian,et al. The role of neuromuscular blockers in ARDS: benefits and risks , 2012, Current opinion in critical care.
[19] M. Tobin,et al. Narrative Review: Ventilator-Induced Respiratory Muscle Weakness , 2010, Annals of Internal Medicine.
[20] G. Scheffer,et al. Toll-like Receptor 4 Signaling in Ventilator-induced Diaphragm Atrophy , 2010, Anesthesiology.
[21] S. Powers,et al. Prolonged mechanical ventilation alters diaphragmatic structure and function , 2009, Critical care medicine.
[22] E. Moilanen,et al. Effects of levo‐ and dextrosimendan on NF‐κB‐mediated transcription, iNOS expression and NO production in response to inflammatory stimuli , 2008, British journal of pharmacology.
[23] S. Powers,et al. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. , 2008, Physiological reviews.
[24] M. Decramer,et al. Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function , 2007, Intensive Care Medicine.
[25] M. Decramer,et al. Rocuronium exacerbates mechanical ventilation–induced diaphragm dysfunction in rats , 2006, Critical care medicine.
[26] S. Powers,et al. Mechanical ventilation depresses protein synthesis in the rat diaphragm. , 2004, American journal of respiratory and critical care medicine.
[27] T. Vassilakopoulos,et al. Ventilator-induced diaphragmatic dysfunction. , 2004, American journal of respiratory and critical care medicine.
[28] J. Cleland,et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial , 2002, The Lancet.
[29] H. Westerblad,et al. Contractile response of skeletal muscle to low peroxide concentrations: myofibrillar calcium sensitivity as a likely target for redox-modulation. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] J. Levijoki,et al. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. , 1995, Journal of molecular and cellular cardiology.
[31] N. Kalkkinen,et al. Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. , 1994, The Journal of biological chemistry.
[32] D. Singer,et al. Abnormalities of diaphragmatic muscle in neonates with ventilated lungs. , 1988, The Journal of pediatrics.
[33] L. Heunks,et al. Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.
[34] A. Wagstaff,et al. Levosimendan , 2012, Drugs.
[35] J. Papp,et al. STEERING COMMITTEE AND INVESTIGATORS OF THE LEVOSIMENDAN INFUSION VERSUS DOBUTAMINE (LIDO) STUDY. EFFICACY AND SAFETY OF INTRAVENOUS LEVOSIMENDAN COMPARED WITH DOBUTAMINE IN SEVERE LOWOUTPUT HEART FAILURE (THE LIDO STUDY): A RANDOMISED DOUBLEBLIND TRIAL , 2002 .
[36] D. Dreyfuss,et al. Ventilator-induced lung injury: lessons from experimental studies. , 1998, American journal of respiratory and critical care medicine.